Condensed Interim Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from Operating Activities
Net Loss	$ (7,239,000)	$ (4,251,987)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities
Stock based compensation	559,980	1,102,609
Bad debt expense (recovery)	94,714	(70,004)
Forgiveness of paycheck protection program loan	0	(296,827)
Change in fair market value of warrant liability	(46,521)	148,882
Gain on settlement of loan payable	0	(20,000)
Loss on change in fair market value of contingent consideration (Note 2)	240,000	(0)
Gain on settlement of contingent consideration	(1,700,000)	0
Loss on impairment of goodwill	1,138,203	0
Amortization of right-of-use asset	834,889	539,692
Depreciation and amortization	1,484,968	481,040
Amortization of debt discount	53,646	0
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	(103,343)	113,967
Cost and estimated earnings excess of billings	(234,869)	0
Inventory	(2,612,773)	(313,994)
Vendor deposits	697,558	(925,366)
Prepaid expenses and other current assets	(161,797)	84,828
Income taxes payable	0	(173,716)
Accounts payable and accrued expenses	582,297	(645,183)
Billings in excess of costs and earnings on uncompleted contracts	(1,254,496)	0
Deferred revenue	1,151,496	(422,793)
Due to landlord	(138,724)	0
Operating lease payments	(819,828)	(537,712)
Net Cash Used in Operating Activities	(7,473,600)	(5,186,564)
Cash Flows From Investing Activities
Cash paid for patent costs	(682)	(19,001)
Purchase of machinery and equipment	(46,196)	0
Acquisitions, net of cash acquired (Note 2)	(10)	(5,060,193)
Payments on note payable	(41,730)	0
Note receivable, related party	0	(500,000)
Net Cash Used in Investing Activities	(88,618)	(5,579,194)
Cash Flows From Financing Activities
Payments on financing leases	(5,269)	(4,943)
Proceeds from warrant exercise	0	1,157
Shares repurchased	(149,686)	0
Dividends to preferred shareholders	(1,086,750)	(241,500)
Settlement of loan payable	0	(65,000)
Proceeds from equity raises, net	1,092,000	12,272,440
Net Cash (Used in) Provided by Financing Activities	(149,705)	11,962,154
Net (Decrease) Increase in Cash and equivalents	(7,711,923)	1,196,396
Cash, restricted cash, and cash equivalents beginning	8,768,156	11,757,930
Cash, restricted cash, and cash equivalents ending	1,056,233	12,954,326
Cash paid during the year for:
Interest	101,365	1,022
Income taxes	0	185,105
Supplemental Non-Cash Items
Initial recognition of warrant liability	0	135,125
Shares granted to settle previously recorded liability	0	21,420
Recognition ofright of use asset – operating lease	1,380,658	0
Issuance of Note Payable for payment of prepaid expense	$ 318,833	$ 0